ARCHIVES

Early ADT Doesn’t Offer Survival Advantage—ASCO

This article is from The Cancer Letter archive.

Vol. 30 No. 4 | April 27, 2007

Download PDF Visit The Full Archive

Related Articles

IOM Panel Considering NCI Approach To Research In Minorities, Underserved

June 19, 1998

DCPC Board Approves Concepts Of Six New RFAs Totaling $9.3 Million A Year

May 11, 1984

Pharmacogenomics May Lead To Individualized Treatment

June 25, 2004

Come Out of Labs and Join Picket Pines, Congressman Urges

March 30, 1990

NCI Director Broder’s Year In Review: Avoid Politics, Stay Focused On Science

October 28, 1994

HHS To Announce Final Plan For Coverage Of Patient Care Costs In All Clinical Trials.

July 28, 2000